tiprankstipranks
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market
TCRX
TScan Therapeutics
RESEARCH TOOLSreports

TScan Therapeutics (TCRX) Balance Sheet

355 Followers

TScan Therapeutics Balance Sheet

TScan Therapeutics's total assets for Q4 2025 were $228.79M, a decrease of -12.75% from the previous quarter. TCRX total liabilities were $105.67M for the fiscal quarter, a -10.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 228.79M$ 371.12M$ 272.15M$ 199.09M$ 188.11M
Total Liabilities
$ 105.67M$ 130.15M$ 121.28M$ 99.66M$ 27.33M
Total Equity Gross Minority
$ 123.12M$ 240.97M$ 150.87M$ 99.43M$ 160.78M
Other Metrics
Currency in USD

TScan Therapeutics Debt to Assets